Loading...
|
Please use this identifier to cite or link to this item:
https://tkuir.lib.tku.edu.tw/dspace/handle/987654321/98497
|
Title: | Synthesis and biological evaluation of peptidyl organotrifluoroborates and their corresponding boron analogs |
Authors: | Tsai, Chia-Hua;Lin, Chia-Hung;Hsieh, Ching-Tien;Cai, Chih-Cheng;Lin, Ting-Ju;Liu, Pin-Yi;Lin, Meng-Hsuan;Wu, Meng-Ju;Fu, Chia-Chieh;Wu, Yang-Chang;Chang, Fnag-Rong;Pan, Po-Shen |
Contributors: | 淡江大學化學學系 |
Keywords: | Peptide;Boronic acid;Organotrifluoroborate;Potassium trifluoroborate;HepG2;MDA-MB231 |
Date: | 2014-07-01 |
Issue Date: | 2014-08-08 14:45:22 (UTC+8) |
Publisher: | Springer Netherlands |
Abstract: | Six peptidyl organotrifluoroborates and their corresponding boronate esters and/or boronic acid analogs were designed and synthesized. Their anti-proliferative activity against hepatocellular carcinoma cells (HepG2) and human metastatic breast cancer cells (MDA-MB231) were evaluated by use of an MTT assay. Potassium {4-[(3S,6S,9S)-3,6-dibenzyl-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}trifluoroborate (B6) was potent (IC50 = 29.9 μM) against MDA-MB231, and {4-[(3S,6S,9S)-6-benzyl-3-((benzyloxy)methyl)-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}boronic acid (B9) and Potassium {4-[(3S,6S,9S)-6-benzyl-3-((benzyloxy)methyl)-9-isopropyl-4,7,10-trioxo-11-oxa-2,5,8-triazadodecyl]phenyl}trifluoroborate (B10) had broad anti-proliferative activity against HepG2 (IC50 = 24.7 and 21.8 μM, respectively) and MDA-MB231 (IC50 = 24.5 and 18.9 μM, respectively). |
Relation: | Research on Chemical Intermediates 40(6), pp.2187-2198 |
DOI: | 10.1007/s11164-014-1596-7 |
Appears in Collections: | [化學學系暨研究所] 期刊論文
|
Files in This Item:
File |
Description |
Size | Format | |
index.html | | 0Kb | HTML | 157 | View/Open | Synthesis and biological evaluation of peptidyl organotrifluoroborates and their corresponding boron analogs(RCI).pdf | Main Article | 214Kb | Adobe PDF | 327 | View/Open |
|
All items in 機構典藏 are protected by copyright, with all rights reserved.
|